课题基金 / 基金详情

Immunotherapeutic rescue of steroidogenic function in autoimmune Addison's disease: Pilot Study

Immunotherapeutic rescue of steroidogenic function in autoimmune Addison's disease: Pilot Study
自身免疫性阿狄森氏病类固醇生成功能的免疫治疗挽救:初步研究
批准号:
G0701632/1
负责人:
Simon Pearce
金额:
$19.1万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2008
资助国家:
英国
项目状态:
已结题
起止时间:
2008 至 --

项目摘要

项目成果

Simon Pearce的其他基金

相似基金

相关文献

中文摘要
翻译
自身免疫性爱迪生病是一种慢性疾病,由人体免疫系统攻击并最终破坏肾上腺而引起。这会导致某些对生活和健康至关重要的类固醇激素缺乏,而健康的肾上腺通常会产生这些激素。目前治疗爱迪生病的方法很简单,就是用药片来补充缺失的肾上腺类固醇激素。这让人们感觉更好,但往往不能完全恢复正常,使他们长期依赖类固醇药物(每天2或3剂),有几个长期副作用,以及预期寿命缩短。我们计划采用一种激进的新方法来治疗艾迪森氏病,即试图关闭免疫系统,从而停止对肾上腺的攻击。我们将使用一种安全但有效的治疗方法,名为利妥昔单抗,它可以从血液和组织中移除一种特定类型的免疫细胞,称为B淋巴细胞。在过去的10年里,这种疗法已经用于100多万有血液疾病的人,并以两次4小时的输液形式进行,相隔14天。利妥昔单抗治疗其他几种自身免疫性疾病的结果显示出很大的希望,疾病得到了实质性的改善。由于已知肾上腺组织具有很大的再生能力,一旦免疫攻击消失,剩余的(未被破坏的)肾上腺细胞极有可能再生,使至关重要的类固醇激素的分泌恢复到正常水平。当肾上腺分泌不足或低于必要水平时,人体自然会产生一种肾上腺刺激激素,ACTH-促肾上腺皮质激素。爱迪生患者的ACTH水平非常高,一旦免疫攻击被清除,这将导致肾上腺的再生。这一策略可能首次导致自身免疫性爱迪生S病的根治。
英文摘要
Autoimmune Addison`s disease is a chronic disease caused by the body`s immune system attacking and eventually destroying the adrenal glands. This causes deficiency of certain steroid hormones that are essential for life and wellbeing, which the healthy adrenal glands normally produce. The current approach to treating Addison`s disease is simply to replace the missing adrenal steroid hormones using tablets. This makes people feel better, but often not fully back to normal and leaves them chronically dependent upon steroid medications (2 or 3 doses daily), with several long-term side effects, as well as a reduced life-expectancy. We plan a radical new approach to treatment of Addison`s disease, which is to try to switch off the immune system, so the attack on the adrenal glands ceases. We will use a safe but powerful treatment called rituximab that removes a certain type of immune cell, called the B lymphocyte, from the bloodstream and tissues. This treatment has been used on more than a million people with blood conditions over the last 10 years, and is given as two 4-hour infusions, 14 days apart. The results of rituximab therapy in several other autoimmune disease show great promise, with substantial amelioration of disease. As adrenal tissue is already known to have a great capacity for regeneration, it is highly likely that the remaining (not destroyed) adrenal cells will regenerate, restoring the secretion of the vital steroid hormones to normal, once the immune attack has gone. The body naturally makes an adrenal gland stimulating hormone, ACTH-adrenocorticotropic hormone, when adrenal secretions are deficient or below the necessary levels. People with Addison`s have very high levels of ACTH, and this would cause the regeneration of the adrenal glands once the immune attack has been removed. This strategy could lead to a permanent cure of autoimmune Addison s disease, for the first time.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Does chronic thyroid inflammation explain persistent symptoms in Hashimoto thyroiditis?
  • 批准号:
    MR/Z503617/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $165.32万
  • 财政年份:
    2024
  • 负责人:
    Simon Pearce
  • 依托单位:
Plasma-cell depletion therapy for severe Graves' disease
  • 批准号:
    MR/V005898/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $128.2万
  • 财政年份:
    2021
  • 负责人:
    Simon Pearce
  • 依托单位:
Developmental Clinical Studies- Combined Immunotherapy and Trophic Adrenocortical Stimulation in New Onset Autoimmune Addison's Disease
  • 批准号:
    MR/J002526/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $56.12万
  • 财政年份:
    2012
  • 负责人:
    Simon Pearce
  • 依托单位:
Revival of autochthonous adrenocortical stem cells in autoimmune Addison's disease
  • 批准号:
    G0900001/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $36.61万
  • 财政年份:
    2010
  • 负责人:
    Simon Pearce
  • 依托单位:
国内基金
海外基金
基于Robocup-Rescue的应急响应多主体组织网络模型研究
  • 批准号:
    70803033
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    15.0万元
  • 批准年份:
    2008
  • 负责人:
    汪云峰
  • 依托单位: